Yüklüyor......
Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience()
BACKGROUND: The effect of chemotherapy in metastatic bone sarcomas is poor and the condition is invariably fatal. Therefore, new treatment modalities are intensely needed. Pazopanib is a selective multitargeted tyrosine kinase inhibitor that has proven to be effective in the treatment of metastatic...
Kaydedildi:
| Yayımlandı: | Transl Oncol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Neoplasia Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931211/ https://ncbi.nlm.nih.gov/pubmed/31875575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.12.001 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|